1. Home
  2. BOH vs LQDA Comparison

BOH vs LQDA Comparison

Compare BOH & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank of Hawaii Corporation

BOH

Bank of Hawaii Corporation

HOLD

Current Price

$67.90

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$31.13

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOH
LQDA
Founded
1897
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.1B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BOH
LQDA
Price
$67.90
$31.13
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$72.00
$37.40
AVG Volume (30 Days)
346.7K
1.1M
Earning Date
01-26-2026
11-03-2025
Dividend Yield
4.09%
N/A
EPS Growth
22.78
N/A
EPS
4.09
N/A
Revenue
$677,459,000.00
$69,216,000.00
Revenue This Year
$15.10
$994.17
Revenue Next Year
$8.26
$169.25
P/E Ratio
$16.71
N/A
Revenue Growth
8.56
343.41
52 Week Low
$57.45
$11.26
52 Week High
$76.00
$36.41

Technical Indicators

Market Signals
Indicator
BOH
LQDA
Relative Strength Index (RSI) 47.91 42.54
Support Level $70.28 $33.45
Resistance Level $70.34 $35.20
Average True Range (ATR) 1.09 1.54
MACD -0.37 -0.53
Stochastic Oscillator 22.25 2.83

Price Performance

Historical Comparison
BOH
LQDA

About BOH Bank of Hawaii Corporation

Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: